Minireviews
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Methodol. Jun 20, 2025; 15(2): 101430
Published online Jun 20, 2025. doi: 10.5662/wjm.v15.i2.101430
Fecal microbiota transplantation in allergic diseases
Ece Tüsüz Önata, Öner Özdemir
Ece Tüsüz Önata, Öner Özdemir, Division of Pediatric Allergy and Immunology, Medical Faculty, Sakarya University, Adapazarı 54100, Sakarya, Türkiye
Author contributions: Tüsüz Önata E and Özdemir Ö performed the research, wrote the article. All authors have read and approved the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Öner Özdemir, MD, Professor, Division of Pediatric Allergy and Immunology, Medical Faculty, Sakarya University, Adnan Menderes cad, Adapazarı 54100, Sakarya, Türkiye. ozdemir_oner@hotmail.com
Received: September 13, 2024
Revised: October 17, 2024
Accepted: November 1, 2024
Published online: June 20, 2025
Processing time: 74 Days and 15.1 Hours
Core Tip

Core Tip: Fecal microbiota transplantation (FMT) studies have gained popularity after probiotic, prebiotic, symbiotic studies in the treatment of dysbiosis and related diseases. FMT is the process of transferring faeces from a healthy donor to another recipient in order to restore the gut microbiota and provide a therapeutic benefit.